查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828235

2025年結構性心臟全球市場報告

Structural Heart Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，結構性心臟病市場規模強勁成長，從2024年的149億美元成長到2025年的158.9億美元，複合年成長率為6.6%。預測期內的成長可歸因於認知度和篩檢的提高、供應鏈的韌性、醫療支出的增加、市場集中度的提升以及人們對心血管疾病認知的不斷提高。

預計未來幾年結構性心臟市場規模將強勁成長，到2029年將達到224.8億美元，複合年成長率為9.1%。預測期內的成長歸因於心臟瓣膜裝置的需求、人口老化、心血管疾病負擔的增加、市場區隔以及區域市場的成長。預測期內的主要趨勢包括產品發布、技術進步、經濟復甦、監管收緊、心血管疾病負擔的增加以及創新醫療設備。

結構性心臟病學是循環系統的一個分支學科，致力於診斷和治療心臟結構性異常和疾病，特別是影響瓣膜、心室和周圍結構的疾病。此領域通常涉及在導管室進行的微創手術，而非傳統的開胸手術。

結構性心臟產品的主要類別包括封堵器、環狀成形術環、心臟瓣膜球囊和其他相關設備。封堵器專門設計用於提供導管，以便將設備輸送到心腔、冠狀動脈和周邊血管。這些設備用於治療某些類型的心房中膈缺損症（特徵是右心房或心室擴大），以防止異常栓塞。使用結構性心臟產品的各種手術包括治療心臟瓣膜狹窄、心臟瓣膜逆流和左心耳阻塞。這些手術面向各種最終用戶，包括醫院、門診手術中心和心臟中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供結構性心臟市場統計數據，例如結構性心臟行業的全球市場規模、區域佔有率、結構性心臟市場佔有率的競爭對手、詳細的結構性心臟市場細分、市場趨勢和機遇，以及您在結構性心臟行業取得成功所需的數據。這份結構性心臟市場研究報告對該行業的現狀和未來走勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

我們預測未來五年該市場將成長9.1%，較先前預測略有下降0.2%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國，導致經導管瓣膜和輸送系統等關鍵部件的供應鏈中斷，這些部件來自愛爾蘭、德國和哥斯達黎加等主要地區，可能導致治療延誤和手術成本增加。此外，這種影響還可能透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，更廣泛地體現出來。

預計心血管疾病的增加將在未來幾年推動結構性心臟市場的成長。心血管疾病包括影響心臟和血管的疾病，例如冠狀動脈疾病，心臟衰竭和中風。心血管疾病盛行率的增加主要是由於人口老化，生活方式和飲食習慣的改變以及肥胖和糖尿病發病率上升等因素。結構性心臟設備和服務在影響心臟瓣膜，心室和周圍組織的異常和疾病的診斷和治療中起著關鍵作用。採用微創手術取代開心手術可以實現更有效的治療並減少併發症的風險。例如，根據美國心臟病學會於 2022 年 8 月發布的一份報告，預計 2025 年至 2060 年間美國所有四種心血管風險因素都將增加，其中糖尿病患者預計將達到 5500 萬，成長 39.3％。

肥胖趨勢預計將促進結構性心臟市場擴張。肥胖是一種以體內脂肪過度堆積為特徵的疾病，會導致身體質量指數 (BMI) 達到或超過 30，並增加心血管疾病的風險。全球肥胖症的流行推動了對先進結構性心臟干預措施的需求，以應對肥胖導致的心血管風險增加。世界肥胖聯合會 2022 年 5 月的報告指出，到 2030 年，全球將有 10 億人患有肥胖症，其中包括五分之一的女性和七分之一的男性；預計到 2035 年，這一數字將增至 40 億，佔全球人口的 51%。因此，肥胖盛行率的上升對結構性心臟市場的成長產生了重大影響。

技術進步已成為推動結構性心臟病市場發展的突出趨勢。主要市場參與企業正專注於開發創新產品以鞏固其市場地位。例如，2023 年 2 月，美國數位健康公司 Eko Health 推出了 SENSORA，這是一個心臟病檢測平台，利用人工智慧在基層醫療中進行非侵入性心臟病檢測。 SENSORA 使用數位聽診器捕捉和分析心音和電訊號，識別結構性雜音（心臟瓣膜疾病的徵兆），並支持關鍵決策。該技術透過減少治療延遲、住院時間和再入院率來提高營運效率，有助於提高患者和醫生的滿意度。

結構性心臟市場的主要參與企業正在創新先進產品，例如經導管邊緣到邊緣修復 (TEER) 系統，以改善心臟瓣膜疾病的微創治療選擇。 TEER 系統是一種旨在治療心臟瓣膜疾病，特別是瓣膜閉鎖不全的微創醫療設備。例如，2024 年 4 月，美國醫療設備公司雅培實驗室的一種名為 TriClip 的設備獲得了美國食品藥物管理局(FDA) 的核准， 美國聯邦機構。 TriClip 是一種透過腿部靜脈插入的創新 TEER 系統，即使對於因年齡或已有疾病而處於高風險的患者，也無需進行開心手術即可進行瓣膜修復。該設備使用夾子抓住並連接三尖瓣小葉，減少逆流並改善血流。

2022年2月，總部位於新加坡的醫療科技公司Genesis MedTech收購了美國結構性心臟病公司JC Medical (JCM)，收購金額未揭露。此次收購將增強Genesis MedTech的產品系列，推出微創經導管主動脈瓣置換術(TAVR)裝置J-Valve，為結構性心臟病提供全面的解決方案，從而鞏固其市場地位。

結構性心臟市場由提供患者評估、診斷、治療計劃、外科手術或介入治療以及後續後續觀察等服務的營業單位所獲得的收益構成。市場規模還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。結構性心臟市場還包括經導管心臟瓣膜、封堵器以及手術過程中使用的植入式器械的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 世界的結構核心：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球結構性心臟市場：成長率分析
  • 全球結構性心臟市場表現：規模與成長，2019-2024
  • 全球結構性心臟市場預測：2024-2029年、2034年規模與成長
  • 全球結構性心臟：總目標市場（TAM）

第6章 市場細分

  • 全球結構性心臟市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 封堵器
  • 環狀成形術環
  • 心臟瓣膜球囊
  • 其他
  • 全球結構性心臟市場（依手術程序、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 心臟瓣膜狹窄
  • 心臟瓣膜逆流
  • 左心耳封堵術
  • 全球結構性心臟市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 心臟中心
  • 全球結構性心臟市場：封堵器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心房間隔缺損 (ASD) 封堵器
  • 卵圓孔未閉合（PFO）封堵器
  • 室間隔缺損 (VSD) 封堵器
  • 全球結構性心臟市場：環狀成形術術環細分，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 硬質環狀成形術環
  • 軟環狀成形術圈
  • 可調式環狀成形術環
  • 全球結構性心臟市場：心臟瓣膜球囊細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 球囊擴張心臟瓣膜系統
  • 瓣環成形球囊
  • 全球結構性心臟市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 經導管心臟瓣膜
  • 結構性心臟影像設備
  • 結構性心臟手術系統

第7章 區域和國家分析

  • 全球結構性心臟市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球結構性心臟市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 結構性心臟市場：競爭格局
  • 結構性心臟市場：公司簡介
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • Trane Technologies

第31章：其他領先和創新企業

  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Biomerics LLC
  • Venus Medtech（Hangzhou）Inc.
  • Cryolife Inc.
  • Endologix Inc.
  • Shockwave Medica Inc.
  • Braile Biomedica
  • JenaValve Technology Inc.
  • Corvia Medical Inc
  • HLT Medical
  • On-X Life Technologies Inc.
  • Symetis SA
  • Magenta Therapeutics
  • PASCAL Medical

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年結構性心臟市場：提供新機會的國家
  • 2029年結構性心臟市場：細分領域帶來新機會
  • 2029年結構性心臟市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25335u

Structural heart is a subspecialty within cardiology that concentrates on diagnosing and treating structural abnormalities or diseases of the heart, particularly those impacting the valves, chambers, and surrounding structures. This field typically involves minimally invasive procedures conducted in a catheterization laboratory as opposed to traditional open-heart surgery.

The primary categories of structural heart products encompass occluders, annuloplasty rings, heart valve balloons, and other related devices. Occluder systems are specifically designed to provide a conduit for delivering devices into the heart's chambers, coronary arteries, and peripheral vasculature. These devices are utilized in patients with specific types of atrial septal defects featuring right atrial or ventricle enlargement, preventing paradoxical embolism. The diverse procedures employing structural heart products include heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. These procedures cater to various end-users such as hospitals, ambulatory surgical centers, and cardiac centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The structural heart market research report is one of a series of new reports from The Business Research Company that provides structural heart market statistics, including structural heart industry global market size, regional shares, competitors with a structural heart market share, detailed structural heart market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart industry. This structural heart market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The structural heart market size has grown strongly in recent years. It will grow from $14.9 billion in 2024 to $15.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased awareness and screening, supply chain resilience, increasing healthcare expenditure, market concentration, and increasing awareness of cardiovascular diseases.

The structural heart market size is expected to see strong growth in the next few years. It will grow to $22.48 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the demand for heart valve devices, aging population, growing burden of cardiovascular diseases, market segmentation, regional market growth. Major trends in the forecast period include product launches, technological advancements, economic recovery, regulatory impositions, rising incidences of cardiovascular diseases, and innovative medical devices.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like transcatheter valves and delivery systems, sourced from key regions such as Ireland, Germany, and Costa Rica, which could lead to treatment delays and increased procedure costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cardiovascular disorders is expected to drive the growth of the structural heart market in the future. Cardiovascular disorders encompass diseases affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increasing prevalence of cardiovascular disorders is primarily attributed to factors such as the aging population, shifts in lifestyle and diet, and escalating rates of obesity and diabetes. Structural heart devices and services play a crucial role in diagnosing and treating anomalies or disorders affecting the valves, chambers, and surrounding tissues of the heart, employing minimally invasive procedures instead of open-heart surgery to ensure efficient treatment with lower-risk complications. For example, a report published by the American College of Cardiology in August 2022 highlighted the projected increase in all four cardiovascular risk factors in the United States between 2025 and 2060, with diabetes expected to see a 39.3% rise to 55 million individuals, underscoring the significant role of cardiovascular disorders in propelling the structural heart market's growth.

The upward trend in obesity rates is anticipated to contribute to the expansion of the structural heart market. Obesity, characterized by excessive body fat accumulation resulting in a body mass index (BMI) of 30 or higher, is a medical condition associated with heightened cardiovascular challenges. The persistent global obesity epidemic drives the demand for advanced structural heart interventions to address the increased cardiovascular risks linked to obesity. As indicated by a report from the World Obesity Federation in May 2022, it is projected that by 2030, one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity, and this number is expected to increase to 4 billion people or 51% of the global population by 2035. Thus, the escalating rates of obesity are instrumental in steering the growth of the structural heart market.

Technological advancements have emerged as a prominent trend gaining traction in the structural heart market. Leading market players are channeling their efforts into creating innovative products to strengthen their market position. For instance, in February 2023, Eko Health, a US-based digital health company, introduced the SENSORA cardiac disease detection platform, utilizing artificial intelligence for non-invasive heart disease detection in primary care. SENSORA features digital stethoscopes to capture and analyze heart sounds and electrical signals, aiding in key decision-making by identifying structural murmurs, a sign of valvular heart disease. This technology enhances operational efficiency by reducing delays in care delivery, length of stay, and readmission rates, contributing to both patient and physician satisfaction.

Key players in the structural heart market are innovating advanced products, including transcatheter edge-to-edge repair (TEER) systems, to improve minimally invasive treatment options for heart valve diseases. TEER systems are minimally invasive medical devices designed to address heart valve conditions, particularly mitral valve regurgitation. For example, in April 2024, Abbott Laboratories, a US-based medical device firm, gained approval from the Food and Drug Administration (FDA), a US federal agency responsible for safeguarding public health, for its device called TriClip. TriClip is an innovative TEER system that is delivered through a vein in the leg, allowing for valve repair without the need for open-heart surgery, making it suitable for patients who might be at greater risk due to age or pre-existing health conditions. The device operates by using clips to grasp and bring together the leaflets of the tricuspid valve, thereby decreasing regurgitation and enhancing blood flow.

In February 2022, Genesis MedTech, a Singapore-based medical technology company, acquired JC Medical (JCM), a US-based company operating in the structural heart market, for an undisclosed amount. This acquisition enables Genesis MedTech to enhance its product portfolio with J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device, reinforcing its position in the market by offering comprehensive solutions for structural heart disease.

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomedica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q'Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the structural heart market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The structural heart market consists of revenues earned by entities by providing services such as patient evaluation, diagnosis, treatment planning, surgical or interventional procedures, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart market also includes sales of transcatheter heart valves, closure devices, and implantable devices that are used during procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Structural Heart Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on structural heart market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for structural heart ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Occluders; Annuloplasty Rings; Heart Valve Balloons; Other Products
  • 2) By Procedure: Heart Valve Stenosis; Heart Valve Regurgitation; Left Atrial Appendage Closure
  • 3) By End Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Occluders: Atrial Septal Defect (ASD) Occluders; Patent Foramen Ovale (PFO) Occluders; Ventricular Septal Defect (VSD) Occluders
  • 2) By Annuloplasty Rings: Rigid Annuloplasty Rings; Flexible Annuloplasty Rings; Adjustable Annuloplasty Rings
  • 3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems; Valvuloplasty Balloons
  • 4) By Other Products: Transcatheter Heart Valves; Structural Heart Imaging Devices; Delivery Systems For Structural Heart Procedures
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Trane Technologies; Lepu Medical Technology Co. Ltd.; LivaNova PLC; Biomerics LLC; Venus Medtech (Hangzhou) Inc.; Cryolife Inc.; Endologix Inc.; Shockwave Medica Inc.; Braile Biomedica; JenaValve Technology Inc.; Corvia Medical Inc; HLT Medical; On-X Life Technologies Inc.; Symetis SA; Magenta Therapeutics; PASCAL Medical; Micro Interventional Devices Inc.; CardioKinetix Inc; Tendyne Holdings Inc.; Q'Apel Medical Inc.; Neovasc Inc.; NVT AG; Z-Medical GmbH + Co. KG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Structural Heart Market Characteristics

3. Structural Heart Market Trends And Strategies

4. Structural Heart Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Structural Heart Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Structural Heart PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Structural Heart Market Growth Rate Analysis
  • 5.4. Global Structural Heart Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Structural Heart Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Structural Heart Total Addressable Market (TAM)

6. Structural Heart Market Segmentation

  • 6.1. Global Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Other Products
  • 6.2. Global Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Valve Stenosis
  • Heart Valve Regurgitation
  • Left Atrial Appendage Closure
  • 6.3. Global Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.4. Global Structural Heart Market, Sub-Segmentation Of Occluders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (ASD) Occluders
  • Patent Foramen Ovale (PFO) Occluders
  • Ventricular Septal Defect (VSD) Occluders
  • 6.5. Global Structural Heart Market, Sub-Segmentation Of Annuloplasty Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rigid Annuloplasty Rings
  • Flexible Annuloplasty Rings
  • Adjustable Annuloplasty Rings
  • 6.6. Global Structural Heart Market, Sub-Segmentation Of Heart Valve Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Expandable Heart Valve Systems
  • Valvuloplasty Balloons
  • 6.7. Global Structural Heart Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Structural Heart Imaging Devices
  • Delivery Systems For Structural Heart Procedures

7. Structural Heart Market Regional And Country Analysis

  • 7.1. Global Structural Heart Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Structural Heart Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Structural Heart Market

  • 8.1. Asia-Pacific Structural Heart Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Structural Heart Market

  • 9.1. China Structural Heart Market Overview
  • 9.2. China Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Structural Heart Market

  • 10.1. India Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Structural Heart Market

  • 11.1. Japan Structural Heart Market Overview
  • 11.2. Japan Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Structural Heart Market

  • 12.1. Australia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Structural Heart Market

  • 13.1. Indonesia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Structural Heart Market

  • 14.1. South Korea Structural Heart Market Overview
  • 14.2. South Korea Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Structural Heart Market

  • 15.1. Western Europe Structural Heart Market Overview
  • 15.2. Western Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Structural Heart Market

  • 16.1. UK Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Structural Heart Market

  • 17.1. Germany Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Structural Heart Market

  • 18.1. France Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Structural Heart Market

  • 19.1. Italy Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Structural Heart Market

  • 20.1. Spain Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Structural Heart Market

  • 21.1. Eastern Europe Structural Heart Market Overview
  • 21.2. Eastern Europe Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Structural Heart Market

  • 22.1. Russia Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Structural Heart Market

  • 23.1. North America Structural Heart Market Overview
  • 23.2. North America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Structural Heart Market

  • 24.1. USA Structural Heart Market Overview
  • 24.2. USA Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Structural Heart Market

  • 25.1. Canada Structural Heart Market Overview
  • 25.2. Canada Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Structural Heart Market

  • 26.1. South America Structural Heart Market Overview
  • 26.2. South America Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Structural Heart Market

  • 27.1. Brazil Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Structural Heart Market

  • 28.1. Middle East Structural Heart Market Overview
  • 28.2. Middle East Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Structural Heart Market

  • 29.1. Africa Structural Heart Market Overview
  • 29.2. Africa Structural Heart Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Structural Heart Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Structural Heart Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Structural Heart Market Competitive Landscape And Company Profiles

  • 30.1. Structural Heart Market Competitive Landscape
  • 30.2. Structural Heart Market Company Profiles
    • 30.2.1. Abbott Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Trane Technologies Overview, Products and Services, Strategy and Financial Analysis

31. Structural Heart Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology Co. Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Biomerics LLC
  • 31.4. Venus Medtech (Hangzhou) Inc.
  • 31.5. Cryolife Inc.
  • 31.6. Endologix Inc.
  • 31.7. Shockwave Medica Inc.
  • 31.8. Braile Biomedica
  • 31.9. JenaValve Technology Inc.
  • 31.10. Corvia Medical Inc
  • 31.11. HLT Medical
  • 31.12. On-X Life Technologies Inc.
  • 31.13. Symetis SA
  • 31.14. Magenta Therapeutics
  • 31.15. PASCAL Medical

32. Global Structural Heart Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Structural Heart Market

34. Recent Developments In The Structural Heart Market

35. Structural Heart Market High Potential Countries, Segments and Strategies

  • 35.1 Structural Heart Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Structural Heart Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Structural Heart Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer